Establishment of a system for individual cost accounting and cost management for the cancer precision medicine-related business
First written in FY2020-Q1. 2 of 3 entries say "Restated". Latest entry: FY2020-Q3.
No other company in this theme has enough history to compare yet.
- FY2020-Q3RestatedAnnual report
「In the Group's precision oncology business, individual costing based on actual costs has been applied from the first quarter of the current consolidated fiscal year.」
The company continues to apply individual costing based on actual costs and a cost control framework to the precision oncology business. - FY2020-Q2RestatedAnnual report
「In the Group's precision oncology business, individual costing based on actual costs has been applied from the first quarter of the current consolidated fiscal year.」
The company continues to apply individual costing based on actual costs and a cost control system to the precision oncology business. - FY2020-Q1First statedAnnual report
「In the Group's precision oncology business, individual costing based on actual costs has been applied from the first quarter of the current consolidated fiscal year. Since the launch of this business, the Group has worked to establish an operating framework for its analytical services. During the quarter, this framework, including a cost accounting system, was put in place to strengthen cost control and for other purposes.」
For the precision oncology business, individual costing based on actual costs was applied from April 2019, and a cost control framework, including a cost accounting system, was established.